These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34774541)

  • 1. Immunocompetent rabbits infected with Cryptosporidium cuniculus as an animal model for anti-cryptosporidial drug testing.
    Lu C; Liu X; Liu J; Tang X; Zhu G; Striepen B; Suo X
    Int J Parasitol; 2022 Mar; 52(4):205-210. PubMed ID: 34774541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
    Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
    Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in genetic manipulation of Cryptosporidium.
    Vinayak S
    Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice.
    Farid A; Yousry M; Safwat G
    J Ethnopharmacol; 2022 Jun; 292():115174. PubMed ID: 35259443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein.
    Liu M; Zhang D; Wang D; Wu X; Zhang Y; Yin J; Zhu G
    J Infect Dis; 2023 Nov; 228(10):1430-1440. PubMed ID: 37418629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.
    Zhang CX; Love MS; McNamara CW; Chi V; Woods AK; Joseph S; Schaefer DA; Betzer DP; Riggs MW; Iroh Tam PY; Van Voorhis WC; Arnold SLM
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156021. PubMed ID: 34748385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
    Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
    Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic screening techniques for
    Love MS; McNamara CW
    Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
    [No Abstract]   [Full Text] [Related]  

  • 10. Cryptosporidial infection in children with inflammatory bowel disease.
    Vadlamudi N; Maclin J; Dimmitt RA; Thame KA
    J Crohns Colitis; 2013 Oct; 7(9):e337-43. PubMed ID: 23415795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A "One-Health" Concern.
    Ali M; Xu C; Nawaz S; Ahmed AE; Hina Q; Li K
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
    Caravedo MA; White AC
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):167-173. PubMed ID: 36533398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cryptosporidial drug activity screened with an immunosuppressed rat model.
    Brasseur P; Lemeteil D; Ballet JJ
    J Protozool; 1991; 38(6):230S-231S. PubMed ID: 1818183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment and novel drug target against Cryptosporidium.
    Gargala G
    Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children.
    Abraham DR; Rabie H; Cotton MF
    Pediatr Infect Dis J; 2008 Nov; 27(11):1040-1. PubMed ID: 18985834
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptosporidium and cryptosporidiosis.
    Soave R; Armstrong D
    Rev Infect Dis; 1986; 8(6):1012-23. PubMed ID: 3541121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Tools for Cryptosporidium Lead to New Hope for Cryptosporidiosis.
    Ward HD
    Trends Parasitol; 2017 Sep; 33(9):662-664. PubMed ID: 28750950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.